BRM Targeted Compounds and Related Methods of Use

JP2024541479APending Publication Date: 2024-11-08ARVINAS OPERATIONS INC +1
View PDF 11 Cites 0 Cited by

Patent Information

Application Number
JP2024531063
Authority / Receiving Office
JP · JP
Patent Type
Applications
Current Assignee / Owner
Priority Date
2021-11-24
Filing Date
2022-11-23
Publication Date
2024-11-08

Smart Images

  • Figure 2024541479000517
    Figure 2024541479000517
  • Figure 2024541479000001
    Figure 2024541479000001
  • Figure 2024541479000002
    Figure 2024541479000002
Patent Text Reader

Abstract

The present disclosure relates to bifunctional compounds that find utility as modulators of SMARCA2 or BRM (target proteins). In particular, the present disclosure is directed to bifunctional compounds that contain a ligand that binds to von Hippel-Lindau E3 ubiquitin ligase at one end and a moiety that binds to a target protein at the other end, placing the target protein in close proximity to the ubiquitin ligase, resulting in degradation (and inhibition) of the target protein. The present disclosure exhibits a broad range of pharmacological activities related to degradation / inhibition of target proteins. The compounds and compositions of the present disclosure treat or prevent diseases or disorders resulting from the aggregation or accumulation of target proteins.
Need to check novelty before this filing date? Find Prior Art

Citation Information

Patent Citations

  • High-pressure preparation method of confined high-density anhydrous alkali metal polymer nitrogen Cm-NaN5

    CN113387901A

  • BRM Targeted Compounds and Related Methods of Use

    JP2021520350A

  • Small molecule degraders of POLYBROMO-1 (PBRM1)

    JP2021522276A

  • WD40 repeat domain protein 5 (WDR5) degrading / disrupting compounds and methods of use

    JP2021527666A

  • Proteolysis targeting chimera (protacs) as degraders of smarca2 and / or smarca4

    WO2020078933A1